Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
MOVE | US
1.79
59.31%
Healthcare
Medical Devices
30/06/2024
07/04/2026
12.13
9.09
12.98
8.80
Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate heart rate variability (HRV) blood oxygen saturation (SpO2) respiration rate skin temperature variability period and ovulation tracking and menstrual symptom tracking as well as activity profile including steps active minutes and calories burned sleep stages and duration and mood tracking. It also develops System-on-a-Chip (SoC) for blood pressure or continuous glucose monitoring (CGM) systems. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton California.
View LessStrength based on increasing price with high volume
High Current Volume and Positive 1-Day Return
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
High Short-term Volatility
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
621.1%1 month
423.3%3 months
381.5%6 months
1340.8%-
-
1.99
0.01
0.01
-1.24
19.57
-
-27.09M
1.20B
1.20B
-
-3.20K
-
-
-181.25
3.16
0.57
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
11.20
Range1M
447.13
Range3M
1.00K
Rel. volume
10.99
Price X volume
12.78M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Pulse Biosciences Inc | PLSE | Medical Instruments & Supplies | 19.96 | 1.22B | -12.99% | n/a | 32.05% |
| PROCEPT BioRobotics Corporation Common Stock | PRCT | Medical Devices | 23.19 | 1.20B | -2.48% | n/a | 32.18% |
| Tandem Diabetes Care Inc | TNDM | Medical Devices | 18.28 | 1.20B | -4.64% | n/a | 204.00% |
| IRadimed Corporation | IRMD | Medical Devices | 93.49 | 1.18B | -2.27% | 35.49 | 0.47% |
| CONMED Corporation | CNMD | Medical Devices | 34.54 | 1.06B | 1.35% | 21.14 | 109.53% |
| AZTA | AZTA | Medical Instruments & Supplies | 21.71 | 1.06B | -3.90% | n/a | 3.59% |
| INMODE LTD. | INMD | Medical Devices | 13.65 | 1.04B | -0.44% | 10.28 | 0.00% |
| STAAR Surgical Company | STAA | Medical Instruments & Supplies | 21.09 | 1.04B | 0.62% | 94.12 | 8.87% |
| BioLife Solutions Inc | BLFS | Medical Instruments & Supplies | 19.13 | 882.62M | -0.73% | n/a | 11.19% |
| Butterfly Network Inc. | BFLY | Medical Devices | 4.05 | 860.92M | -1.94% | n/a | 12.34% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 41.41 | 1.30B | -2.88% | 51.60 | 88.92% |
| Marcus & Millichap Inc | MMI | Real Estate Services | 26.28 | 1.02B | 1.23% | n/a | 14.11% |
| Janus International Group Inc. | JBI | Building Products & Equipment | 5.03 | 730.97M | 0.60% | 11.62 | 116.21% |
| Comstock Mining Inc | LODE | Real Estate Services | 3.27 | 675.70M | -5.49% | 6.38 | 14.37% |
| Latham Group Inc. | SWIM | Building Products & Equipment | 5.17 | 597.53M | -2.08% | 65.18 | 77.00% |
| Ennis Inc | EBF | Building Products & Equipment | 21.72 | 564.80M | -0.23% | 13.28 | 2.28% |
| The Real Brokerage Inc. Common Shares | REAX | Real Estate Services | 2.45 | 484.50M | -3.16% | n/a | 0.00% |
| FRP Holdings Inc | FRPH | Real Estate Services | 22.13 | 421.14M | -0.23% | 75.50 | 42.65% |
| ACCO Brands Corporation | ACCO | Building Products & Equipment | 2.84 | 272.07M | -1.73% | n/a | 174.23% |
| The RMR Group Inc | RMR | Real Estate Services | 15.81 | 264.42M | -0.50% | 16.64 | 14.14% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -1.24 | 46.09 | Cheaper |
| Ent. to Revenue | 19.57 | 14.34 | Expensive |
| PE Ratio | - | 30.41 | - |
| Price to Book | 1.99 | 6.21 | Cheaper |
| Dividend Yield | - | 1.78 | - |
| Std. Deviation (3M) | 381.49 | 64.12 | Riskier |
| Debt to Equity | 0.01 | -145.53 | Expensive |
| Debt to Assets | 0.01 | 0.35 | Cheaper |
| Market Cap | 1.20B | 9.70B | Emerging |